Skip to main content

Table 2 clinical variables during treatment in two groups

From: Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study

Variable

T0

T24

T48

T72

T96

SOFA

 Intervention

12.45 ± 2.65

10.27 ± 2.60

7.1 ± 1.92

3.72 ± 1.75

1.62 ± 1.19

 Control

10.7 ± 2.70

8.8 ± 2.65

7.92 ± 2.81

4.85 ± 2.51

3.10 ± 1.61

P value

< 0.001

0.01

0.93

0.01

< 0.001

PCT

 Intervention

37.25 ± 20.93

26.50 ± 15.30

11.10 ± 6.04

4.02 ± 2.34

1.36 ± 0.79

 Control

45.28 ± 28.60

28.07 ± 17.48

16.27 ± 11.71

7.72 ± 7.29

2.82 ± 1.39

P value

0.15

0.67

0.01

< 0.001

< 0.001

CRP

 Intervention

27.40 ± 11.66

36.60 ± 13.85

14.97 ± 7.31

6.70 ± 3.61

2.30 ± 0.66

 Control

24.27 ± 12.83

45.1 ± 19.50

24.32 ± 12.72

11.47 ± 7.51

4.79 ± 1.78

P value

0.25

0.02

< 0.001

< 0.001

< 0.001

Pao2/Fio2

 Intervention

116.42 ± 27.60

191.49 ± 25.60

224.62 ± 23.40

262.87 ± 30.59

292.65 ± 29.42

 Control

160.51 ± 29.70

188.21 ± 26.61

208.50 ± 28.88

229.95 ± 33.10

257.20 ± 33.73

P value

0.99

0.6

< 0.001

< 0.001

< 0.001

Vitamin C

 Intervention

20.63 ± 12.74

   

79.20 ± 26.42

 Control

22.77 ± 13.56

   

16.38 ± 10.33

P value

0.47

   

< 0.001

  1. SOFA Sequential organ failure assessment
  2. PCT Procalcitonin (microgram per liter)
  3. CRP C reactive protein (milligram per liter)
  4. VIT C (milligram per liter)